[Typical immune system responses to differential monotherapy with immune-correcting drugs].
Zemskov
A M
AM
Zemskov
B M
BM
Zoloedov
V I
VI
Lutskii
M A
MA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001249:Asthma / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D005260:Female; D005901:Glaucoma / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D008297:Male; D008581:Meningitis / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D010031:Otitis / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D010455:Peptides / Q000627:therapeutic use; D010510:Periodontal Diseases / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D011210:Power Plants; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D013949:Thymus Extracts / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin